UTI Healthcare Fund-Growth Option- Direct
UTI Healthcare Fund-Growth Option- Direct

UTI Healthcare Fund-Growth Option- Direct

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 160.3 as on 27-01-2023

Fund Performance
zero opening, trading, fund transfer fee
125 people have invested ₹ 8.9L in mutual fund in the last three months

Fund Insights

In the last 1 year, SBI Healthcare Opportunities Fund Direct Growth has given 1.01% return, outperforming this fund by 7.5%

In the last 3 years, DSP Healthcare Fund Direct Growth has given 24.3% return, outperforming this fund by 5.11%

In the last 5 years, Nippon India Pharma Fund - Direct Plan - Growth Plan has given 14.49% return, outperforming this fund by 3.6%

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.
Pros
5Y returns in the top 25% of the category
Beats FD returns for both 3Y & 5Y duration
Cons
3Y returns in the bottom 25% of the category

Fund Performance as on (19-Jan-23)

Return
1M
3M
6M
1Y
3Y
5Y
This Fund
-2.1%
-4.6%
0.6%
-4.8%
19%
10.9%
Benchmark
-2.3%
2.2%
9.6%
-0.5%
15%
9.6%
Category
-2.6%
-4.1%
1.3%
-4.5%
19.4%
12.5%
About the Fund

UTI Healthcare Fund-Growth Option- Direct is an equity fund. This fund was started on  1 January, 2013. The fund is managed by V Srivatsa, Kamal Gada. The fund could potentially beat inflation in the long-run.

Key parameters

1) UTI Healthcare Fund-Growth Option- Direct has a NAV of 160.3461 as on 27-01-2023.

2) UTI Healthcare Fund-Growth Option- Direct has 691 Cr worth of assets under management (AUM) as on 30-11-2022 and is less than category average.

3) The fund has an expense ratio 1.46 %.

Fund Overview

Expense ratio
Expense ratio
1.46%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹691 Cr
Inception Date
Inception Date
1 January, 2013
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
43.4%

Fund Distribution as on (31-Dec-22)

  • Equity 97.8%
  • Debt & Cash 2.2%
Size breakup
Large cap
42%
Small cap
29.8%
Mid cap
26%

Sector Allocation

Dec'22

Nov'22

Oct'22

Health

98.3%

Basic Materials

1.7%

Top Holdings as on (31-Dec-22)

  • Equity
  • Debt & Cash
Equity Holdings32
Debt Holdings2

What changed

in last one month
  • Scheme
  • Portfolio
AUM decreased by 29.1 Cr in last 1M
Dec'22 return underperformed benchmark

Change in AUM

Dec'22
₹ 691.5 Cr
Nov'22
₹ 720.6 Cr
Oct'22
₹ 725.4 Cr

Fund Returns vs Benchmark

Dec'22
2.33%
5.37%
Nov'22
0.25%
2.63%
Oct'22
2.33%
5.37%
Fund Return
Benchmark Return

Concentration Analysis as on (31-Dec-22)

Fund
Dec'22
Nov'22
Oct'22
No of Holdings
34
34
33
Top 5 Company Concentration
39.9%
40.5%
39.8%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (13.6%)
Sun Pharmaceuticals Industries Ltd (13.6%)
Sun Pharmaceuticals Industries Ltd (13%)
No of Sectors
4
4
4
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (96.2%)
Health (96.9%)
Health (96.5%)

Fund Manager

V Srivatsa

V Srivatsa

Fund Manager of UTI Healthcare Fund-Growth Option- Direct, since 3 March 2017
Kamal Gada

Kamal Gada

Fund Manager of UTI Healthcare Fund-Growth Option- Direct, since 2 May 2022

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
UTI Healthcare Fund-Growth Option- Direct
19.19%
19.45%

AMC details

Fund House
UTI Asset Management Co Ltd
Total Schemes
Total AUM
₹1.68L Cr
as on 31-Dec-2022
Address
PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051
Phone
+912266786666
Email
service@uti.co.in

Fund Highlights

meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 12.8% since inception which is less than its category average return of 15.5%
Fund Allocations

Fund Allocations

This fund has an allocation of 97.82% in Equity, 0.18% in Debt and 1.99% in Cash related instruments
AUM size ₹691 Cr

AUM size ₹691 Cr

This fund has AUM of ₹691 Cr which is less than its category average of ₹ 1318 Cr
Expense Ratio 1.46%

Expense Ratio 1.46%

This fund has an expense ratio of 1.46% which is less than its category average expense ratio of 1.54%

Frequently Asked Questions

The current NAV of UTI Healthcare Fund-Growth Option- Direct is 163.44 as on 19-Jan-2023.
Existing (Absolute + CAGR)
UTI Healthcare Fund-Growth Option- Direct
Absolute Returns
CAGR Returns
1 Month Returns
-0.05%
-0.05%
6 Month Returns
1.76%
1.76%
1 Year Returns
-8.16%
-8.16%
3 Years Returns
72.81%
20%
5 Years Returns
72.28%
11.49%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.46 as on December 2022
691 Cr as on December 2022
Sun Pharmaceuticals Industries Ltd(13.58%),Cipla Ltd(8.54%),Dr Reddy's Laboratories Ltd(6.65%),Apollo Hospitals Enterprise Ltd(6.48%),Fortis Healthcare Ltd(4.68%) as on December 2022
Health(96.18%),Cash Equivalent(1.99%),Basic Materials(1.65%) as on December 2022
The alpha ratio for the UTI Healthcare Fund-Growth Option- Direct for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
UTI Healthcare Fund-Growth Option- Direct
-0.97
1.96
1.7
As on December 2022
The alpha for UTI Healthcare Fund-Growth Option- Direct is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the UTI Healthcare Fund-Growth Option- Direct for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
UTI Healthcare Fund-Growth Option- Direct
0.93
0.93
0.91
As on December 2022
The Beta for UTI Healthcare Fund-Growth Option- Direct is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the UTI Healthcare Fund-Growth Option- Direct for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
UTI Healthcare Fund-Growth Option- Direct
-1.1
0.84
0.4
As on December 2022
The sharpe ratio for UTI Healthcare Fund-Growth Option- Direct is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the UTI Healthcare Fund-Growth Option- Direct for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
UTI Healthcare Fund-Growth Option- Direct
14.53
21.09
19.19
As on December 2022
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.85 as on December 2022. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.31 as on December 2022. It tells the consistency of the fund in generating superior risk-adjusted performance
V Srivatsa,Kamal Gada are the fund managers of UTI Healthcare Fund-Growth Option- Direct
The Exit load of UTI Healthcare Fund-Growth Option- Direct is 1%

Mutual Fund execution provided by

Technology facilitation Services provided by Finzoom Investment Advisors Pvt. Ltd. - Advisory unit. SEBI Registered Investment Advisor: INA100012190 | BASL Registration No. 1154 | BSE StarMF Platform code: 24801

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future returns.